PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1115
https://www.valueinhealthjournal.com/article/S1098-3015(12)02828-8/fulltext
Title : PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02828-8&doi=10.1016/j.jval.2012.08.1115
First page : A393
Section Title : Infection
Open access? : No
Section Order : 617
Categories :
Tags :
Regions :
ViH Article Tags :